WO2012012609A8 - Synthesis of resveratrol-based compounds - Google Patents
Synthesis of resveratrol-based compounds Download PDFInfo
- Publication number
- WO2012012609A8 WO2012012609A8 PCT/US2011/044806 US2011044806W WO2012012609A8 WO 2012012609 A8 WO2012012609 A8 WO 2012012609A8 US 2011044806 W US2011044806 W US 2011044806W WO 2012012609 A8 WO2012012609 A8 WO 2012012609A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- absent
- resveratrol
- synthesis
- based compounds
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/17—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/12—Acetic acid esters
- C07C69/21—Acetic acid esters of hydroxy compounds with more than three hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/093—Polyol derivatives esterified at least twice by phosphoric acid groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
A compound having the structure: bond α is present or absent, wherein when bond α is absent, then R1 is =0 or S(CH2)1-3-phenyl and when bond α is present, then R1 is H, wherein the phenyl is substituted or unsubstituted; R2, R3, R4, R5, R6, R7, R8, R9 and R10 are independently H or OR11 wherein each occurrence of R11 is independently H, methyl, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, phosphate, sulfate, sulfonic ester, or ester; when α is absent and R1 is =0, then R10 is other than OH; and when α is absent and R1 is S(CH2)1-3-phenyl, then R10 is other thanOCH3, or a salt thereof.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/810,093 US20130338390A1 (en) | 2010-07-21 | 2011-07-21 | Synthesis of resveratrol-based compounds |
| EP11810391.0A EP2596002A2 (en) | 2010-07-21 | 2011-07-21 | Synthesis of resveratrol-based compounds |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40011110P | 2010-07-21 | 2010-07-21 | |
| US61/400,111 | 2010-07-21 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| WO2012012609A2 WO2012012609A2 (en) | 2012-01-26 |
| WO2012012609A8 true WO2012012609A8 (en) | 2012-09-13 |
| WO2012012609A3 WO2012012609A3 (en) | 2014-03-20 |
Family
ID=45497456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2011/044806 Ceased WO2012012609A2 (en) | 2010-07-21 | 2011-07-21 | Synthesis of resveratrol-based compounds |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20130338390A1 (en) |
| EP (1) | EP2596002A2 (en) |
| WO (1) | WO2012012609A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009038731A2 (en) * | 2007-09-17 | 2009-03-26 | The Trustees Of Columbia University In The City Of New York | Synthesis of resveratrol-based natural products |
| CN104045533A (en) * | 2013-03-15 | 2014-09-17 | 复旦大学 | Indanone compound and medicinal application |
| CN105078944A (en) * | 2014-05-11 | 2015-11-25 | 复旦大学 | Application of Isopaucifloral F in preparation of anti-osteoporosis drug |
| EP4039094A1 (en) * | 2021-02-03 | 2022-08-10 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Novel antifungal compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030118617A1 (en) * | 2001-12-21 | 2003-06-26 | Avon Products, Inc. | Resveratrol analogues |
| WO2009038731A2 (en) * | 2007-09-17 | 2009-03-26 | The Trustees Of Columbia University In The City Of New York | Synthesis of resveratrol-based natural products |
-
2011
- 2011-07-21 EP EP11810391.0A patent/EP2596002A2/en not_active Withdrawn
- 2011-07-21 US US13/810,093 patent/US20130338390A1/en not_active Abandoned
- 2011-07-21 WO PCT/US2011/044806 patent/WO2012012609A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20130338390A1 (en) | 2013-12-19 |
| EP2596002A2 (en) | 2013-05-29 |
| WO2012012609A2 (en) | 2012-01-26 |
| WO2012012609A3 (en) | 2014-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY148703A (en) | Polycyclic cinnamide derivatives | |
| MA35452B1 (en) | 3-pyrimidin-4-yl-oxazolidin-2-ones as mutant idh inhibitors | |
| MY150507A (en) | Polycyclic compound | |
| WO2011061452A3 (en) | Bicarbonate precursors, method for preparing same and uses thereof | |
| MY193277A (en) | Certain amino-pyrimidines, compositions thereof, and methods for their use | |
| MX2011008176A (en) | 3, 3' -spiroindolinone derivatives as anticancer agents. | |
| NZ605010A (en) | Novel calcium salts of compound as anti-inflammatory, immunomodulatory and anti-proliferatory agents | |
| IL224450B (en) | Crystalline form of the pyrimido [1,6-a] isoquinoline-4-one compound | |
| PH12012501473A1 (en) | Cycloalkyl-substituted imidazole derivative | |
| WO2013098836A8 (en) | A bis-quinophthalone pigment and a process for preparing the same | |
| WO2012012609A3 (en) | Synthesis of resveratrol-based compounds | |
| WO2009083532A3 (en) | Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained, and uses thereof | |
| WO2011163636A3 (en) | Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms | |
| MX359363B (en) | DIHYDROETORPHINES and THEIR PREPARATION. | |
| WO2011142825A3 (en) | Novel sulfur containing compounds | |
| WO2012082551A3 (en) | Partially fluorinated sulfinic acid monomers and their salts | |
| WO2013045382A3 (en) | Hair composition | |
| WO2010002528A3 (en) | Hydrofluoroacetal compounds and processes for their preparation and use | |
| EA201071424A1 (en) | SOLIDEAPEYE SOLI 2-AMIN-3-КАРБЕКСИАМИНОО-6- (4-ФТОРБЕНЗИЛАМИНО) ПИРИДИНА | |
| WO2013091020A3 (en) | Ophthalmic formulation | |
| EP2578617A4 (en) | Polyamide compound | |
| WO2011157388A8 (en) | Process for the preparation of pteridine derivatives | |
| WO2010070593A3 (en) | Malonate esters | |
| IN2014CN04667A (en) | ||
| WO2011045546A3 (en) | Polyurethane synthesis by means of self-condensation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11810391 Country of ref document: EP Kind code of ref document: A2 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2011810391 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 13810093 Country of ref document: US |